nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.436	1	CbGaD
Methylprednisolone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0541	0.167	CbGbCtD
Methylprednisolone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0541	0.167	CbGbCtD
Methylprednisolone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0375	0.116	CbGbCtD
Methylprednisolone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0324	0.1	CbGbCtD
Methylprednisolone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0301	0.0931	CbGbCtD
Methylprednisolone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0231	0.0714	CbGbCtD
Methylprednisolone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0215	0.0665	CbGbCtD
Methylprednisolone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0212	0.0654	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0144	0.0446	CbGbCtD
Methylprednisolone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0138	0.0428	CbGbCtD
Methylprednisolone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0127	0.0392	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00865	0.0267	CbGbCtD
Methylprednisolone—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.00028	0.41	CrCbGaD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000495	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000119	0.000495	CcSEcCtD
Methylprednisolone—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000494	CcSEcCtD
Methylprednisolone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000118	0.000494	CcSEcCtD
Methylprednisolone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000493	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000118	0.000493	CcSEcCtD
Methylprednisolone—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000492	CcSEcCtD
Methylprednisolone—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000492	CcSEcCtD
Methylprednisolone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000117	0.00049	CcSEcCtD
Methylprednisolone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000117	0.00049	CcSEcCtD
Methylprednisolone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000117	0.000489	CcSEcCtD
Methylprednisolone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000116	0.000486	CcSEcCtD
Methylprednisolone—Malaise—Etoposide—peripheral nervous system neoplasm	0.000116	0.000484	CcSEcCtD
Methylprednisolone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000484	CcSEcCtD
Methylprednisolone—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000115	0.000482	CcSEcCtD
Methylprednisolone—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000115	0.000479	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000478	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000478	CcSEcCtD
Methylprednisolone—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000475	CcSEcCtD
Methylprednisolone—Infection—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000475	CcSEcCtD
Methylprednisolone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000114	0.000475	CcSEcCtD
Methylprednisolone—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000474	CcSEcCtD
Methylprednisolone—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000473	CcSEcCtD
Methylprednisolone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000113	0.000472	CcSEcCtD
Methylprednisolone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000113	0.000471	CcSEcCtD
Methylprednisolone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000113	0.000471	CcSEcCtD
Methylprednisolone—Rash—Topotecan—peripheral nervous system neoplasm	0.000113	0.000471	CcSEcCtD
Methylprednisolone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000113	0.00047	CcSEcCtD
Methylprednisolone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000469	CcSEcCtD
Methylprednisolone—Headache—Topotecan—peripheral nervous system neoplasm	0.000112	0.000468	CcSEcCtD
Methylprednisolone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000112	0.000467	CcSEcCtD
Methylprednisolone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000112	0.000467	CcSEcCtD
Methylprednisolone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000467	CcSEcCtD
Methylprednisolone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000112	0.000467	CcSEcCtD
Methylprednisolone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000112	0.000467	CcSEcCtD
Methylprednisolone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000112	0.000466	CcSEcCtD
Methylprednisolone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000111	0.000465	CcSEcCtD
Methylprednisolone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000111	0.000465	CcSEcCtD
Methylprednisolone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000465	CcSEcCtD
Methylprednisolone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000111	0.000464	CcSEcCtD
Methylprednisolone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000111	0.000464	CcSEcCtD
Methylprednisolone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000111	0.000464	CcSEcCtD
Methylprednisolone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.000463	CcSEcCtD
Methylprednisolone—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000462	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000462	CcSEcCtD
Methylprednisolone—Rash—Melphalan—peripheral nervous system neoplasm	0.00011	0.000461	CcSEcCtD
Methylprednisolone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00011	0.000461	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000459	CcSEcCtD
Methylprednisolone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000455	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000109	0.000454	CcSEcCtD
Methylprednisolone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000108	0.000452	CcSEcCtD
Methylprednisolone—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000452	CcSEcCtD
Methylprednisolone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000447	CcSEcCtD
Methylprednisolone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.000446	CcSEcCtD
Methylprednisolone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000446	CcSEcCtD
Methylprednisolone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000106	0.000444	CcSEcCtD
Methylprednisolone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000106	0.000444	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000106	0.000442	CcSEcCtD
Methylprednisolone—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000106	0.000442	CcSEcCtD
Methylprednisolone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000441	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000441	CcSEcCtD
Methylprednisolone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000105	0.00044	CcSEcCtD
Methylprednisolone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000105	0.00044	CcSEcCtD
Methylprednisolone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00044	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000105	0.000438	CcSEcCtD
Methylprednisolone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000438	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000104	0.000436	CcSEcCtD
Methylprednisolone—Infection—Etoposide—peripheral nervous system neoplasm	0.000104	0.000435	CcSEcCtD
Methylprednisolone—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000435	CcSEcCtD
Methylprednisolone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000104	0.000434	CcSEcCtD
Methylprednisolone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000104	0.000434	CcSEcCtD
Methylprednisolone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000103	0.000429	CcSEcCtD
Methylprednisolone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000102	0.000428	CcSEcCtD
Methylprednisolone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000102	0.000428	CcSEcCtD
Methylprednisolone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000102	0.000426	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000101	0.000424	CcSEcCtD
Methylprednisolone—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000423	CcSEcCtD
Methylprednisolone—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000418	CcSEcCtD
Methylprednisolone—Prednisone—ABCB1—peripheral nervous system neoplasm	9.94e-05	0.146	CrCbGaD
Methylprednisolone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	9.92e-05	0.000414	CcSEcCtD
Methylprednisolone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	9.9e-05	0.000414	CcSEcCtD
Methylprednisolone—Hypotension—Etoposide—peripheral nervous system neoplasm	9.8e-05	0.000409	CcSEcCtD
Methylprednisolone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000408	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000408	CcSEcCtD
Methylprednisolone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.64e-05	0.000403	CcSEcCtD
Methylprednisolone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	9.63e-05	0.000402	CcSEcCtD
Methylprednisolone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.54e-05	0.000399	CcSEcCtD
Methylprednisolone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.51e-05	0.000397	CcSEcCtD
Methylprednisolone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	9.43e-05	0.000394	CcSEcCtD
Methylprednisolone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.42e-05	0.000393	CcSEcCtD
Methylprednisolone—Weight increased—Epirubicin—peripheral nervous system neoplasm	9.41e-05	0.000393	CcSEcCtD
Methylprednisolone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000392	CcSEcCtD
Methylprednisolone—Asthenia—Vincristine—peripheral nervous system neoplasm	9.29e-05	0.000388	CcSEcCtD
Methylprednisolone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000385	CcSEcCtD
Methylprednisolone—Infestation—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000385	CcSEcCtD
Methylprednisolone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.21e-05	0.000385	CcSEcCtD
Methylprednisolone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.19e-05	0.000384	CcSEcCtD
Methylprednisolone—Prednisolone—ABCB1—peripheral nervous system neoplasm	9.17e-05	0.134	CrCbGaD
Methylprednisolone—Rash—Dactinomycin—peripheral nervous system neoplasm	9.14e-05	0.000382	CcSEcCtD
Methylprednisolone—Fatigue—Etoposide—peripheral nervous system neoplasm	9.04e-05	0.000378	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.000378	CcSEcCtD
Methylprednisolone—Betamethasone—ABCB1—peripheral nervous system neoplasm	8.98e-05	0.131	CrCbGaD
Methylprednisolone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.89e-05	0.000371	CcSEcCtD
Methylprednisolone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.86e-05	0.00037	CcSEcCtD
Methylprednisolone—Sweating—Epirubicin—peripheral nervous system neoplasm	8.84e-05	0.000369	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.000364	CcSEcCtD
Methylprednisolone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.64e-05	0.000361	CcSEcCtD
Methylprednisolone—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.61e-05	0.00036	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.58e-05	0.000358	CcSEcCtD
Methylprednisolone—Dizziness—Vincristine—peripheral nervous system neoplasm	8.56e-05	0.000358	CcSEcCtD
Methylprednisolone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.54e-05	0.000357	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000356	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000356	CcSEcCtD
Methylprednisolone—Rash—Alitretinoin—peripheral nervous system neoplasm	8.47e-05	0.000354	CcSEcCtD
Methylprednisolone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.46e-05	0.000354	CcSEcCtD
Methylprednisolone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.44e-05	0.000352	CcSEcCtD
Methylprednisolone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	8.43e-05	0.000352	CcSEcCtD
Methylprednisolone—Headache—Alitretinoin—peripheral nervous system neoplasm	8.42e-05	0.000352	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000349	CcSEcCtD
Methylprednisolone—Urticaria—Etoposide—peripheral nervous system neoplasm	8.33e-05	0.000348	CcSEcCtD
Methylprednisolone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000347	CcSEcCtD
Methylprednisolone—Rhinitis—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000347	CcSEcCtD
Methylprednisolone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.29e-05	0.000346	CcSEcCtD
Methylprednisolone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000346	CcSEcCtD
Methylprednisolone—Vomiting—Vincristine—peripheral nervous system neoplasm	8.23e-05	0.000344	CcSEcCtD
Methylprednisolone—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.21e-05	0.000343	CcSEcCtD
Methylprednisolone—Sweating—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000342	CcSEcCtD
Methylprednisolone—Rash—Vincristine—peripheral nervous system neoplasm	8.16e-05	0.000341	CcSEcCtD
Methylprednisolone—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.16e-05	0.000341	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.00034	CcSEcCtD
Methylprednisolone—Headache—Vincristine—peripheral nervous system neoplasm	8.11e-05	0.000339	CcSEcCtD
Methylprednisolone—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.98e-05	0.000333	CcSEcCtD
Methylprednisolone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.000333	CcSEcCtD
Methylprednisolone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.83e-05	0.000327	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	7.8e-05	0.000326	CcSEcCtD
Methylprednisolone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000323	CcSEcCtD
Methylprednisolone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.73e-05	0.000323	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000322	CcSEcCtD
Methylprednisolone—Nausea—Vincristine—peripheral nervous system neoplasm	7.69e-05	0.000321	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000321	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000321	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.00032	CcSEcCtD
Methylprednisolone—Asthenia—Etoposide—peripheral nervous system neoplasm	7.53e-05	0.000314	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000314	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.000314	CcSEcCtD
Methylprednisolone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000312	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000312	CcSEcCtD
Methylprednisolone—Pruritus—Etoposide—peripheral nervous system neoplasm	7.42e-05	0.00031	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000309	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.38e-05	0.000308	CcSEcCtD
Methylprednisolone—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.28e-05	0.000304	CcSEcCtD
Methylprednisolone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.25e-05	0.000303	CcSEcCtD
Methylprednisolone—Rash—Cisplatin—peripheral nervous system neoplasm	7.22e-05	0.000302	CcSEcCtD
Methylprednisolone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.21e-05	0.000301	CcSEcCtD
Methylprednisolone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000301	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000301	CcSEcCtD
Methylprednisolone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.18e-05	0.0003	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.16e-05	0.000299	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000297	CcSEcCtD
Methylprednisolone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	7.01e-05	0.103	CrCbGaD
Methylprednisolone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	6.95e-05	0.00029	CcSEcCtD
Methylprednisolone—Dizziness—Etoposide—peripheral nervous system neoplasm	6.94e-05	0.00029	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000289	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000288	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000286	CcSEcCtD
Methylprednisolone—Nausea—Cisplatin—peripheral nervous system neoplasm	6.8e-05	0.000284	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.71e-05	0.00028	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000279	CcSEcCtD
Methylprednisolone—Vomiting—Etoposide—peripheral nervous system neoplasm	6.67e-05	0.000279	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000278	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000278	CcSEcCtD
Methylprednisolone—Rash—Etoposide—peripheral nervous system neoplasm	6.61e-05	0.000276	CcSEcCtD
Methylprednisolone—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.61e-05	0.000276	CcSEcCtD
Methylprednisolone—Headache—Etoposide—peripheral nervous system neoplasm	6.57e-05	0.000275	CcSEcCtD
Methylprednisolone—Malaise—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.000271	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.00027	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.00027	CcSEcCtD
Methylprednisolone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000265	CcSEcCtD
Methylprednisolone—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.24e-05	0.000261	CcSEcCtD
Methylprednisolone—Nausea—Etoposide—peripheral nervous system neoplasm	6.23e-05	0.00026	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.00026	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000258	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000256	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000256	CcSEcCtD
Methylprednisolone—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000255	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000254	CcSEcCtD
Methylprednisolone—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000253	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000251	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.00025	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.00025	CcSEcCtD
Methylprednisolone—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000248	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000246	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000245	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000244	CcSEcCtD
Methylprednisolone—Shock—Epirubicin—peripheral nervous system neoplasm	5.78e-05	0.000242	CcSEcCtD
Methylprednisolone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.78e-05	0.000241	CcSEcCtD
Methylprednisolone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000241	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.00024	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.00024	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000239	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000237	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000237	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000237	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.000236	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000235	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000234	CcSEcCtD
Methylprednisolone—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.00023	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000229	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000227	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000226	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000224	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.000224	CcSEcCtD
Methylprednisolone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000223	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000222	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000222	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000221	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000221	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.00022	CcSEcCtD
Methylprednisolone—Dexamethasone—ABCB1—peripheral nervous system neoplasm	5.22e-05	0.0765	CrCbGaD
Methylprednisolone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000216	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000212	CcSEcCtD
Methylprednisolone—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000212	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000207	CcSEcCtD
Methylprednisolone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000206	CcSEcCtD
Methylprednisolone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000204	CcSEcCtD
Methylprednisolone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000202	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000201	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.0002	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000196	CcSEcCtD
Methylprednisolone—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000195	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000194	CcSEcCtD
Methylprednisolone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000187	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000186	CcSEcCtD
Methylprednisolone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000181	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000181	CcSEcCtD
Methylprednisolone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.00018	CcSEcCtD
Methylprednisolone—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000176	CcSEcCtD
Methylprednisolone—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000174	CcSEcCtD
Methylprednisolone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000168	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000167	CcSEcCtD
Methylprednisolone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.000163	CcSEcCtD
Methylprednisolone—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.000162	CcSEcCtD
Methylprednisolone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000161	CcSEcCtD
Methylprednisolone—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000156	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000155	CcSEcCtD
Methylprednisolone—Rash—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000155	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000155	CcSEcCtD
Methylprednisolone—Headache—Epirubicin—peripheral nervous system neoplasm	3.68e-05	0.000154	CcSEcCtD
Methylprednisolone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.00015	CcSEcCtD
Methylprednisolone—Nausea—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000146	CcSEcCtD
Methylprednisolone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000144	CcSEcCtD
Methylprednisolone—Rash—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000143	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000143	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—peripheral nervous system neoplasm	3.41e-05	0.000142	CcSEcCtD
Methylprednisolone—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000135	CcSEcCtD
